As baicalein inhibited the retraction phenotype also in CRC/EC intravasation models [7, 15], it was also applied in the CRC/CAF model to highlight a role of ALOX12/15 in the invasion of CRC. The gene discussed is ALOX12; the disease is colorectal carcinoma.